While the U.S. and Europe await the results of large-scale clinical trials before deploying coronavirus vaccines, some other nations are moving much faster with emergency-use rollouts of experimental Chinese and Russian candidates.
A federal judge in San Francisco has partially blocked the Trump administration from enforcing its ban on foreign workers on H-1B and several other types of visa through the end of the year.
Both revenue and quarterly profit were lower than expected, and the maker of athletic apparel chose not to disclose comparable-store sales.
Hope that the drug will succeed as a treatment for Covid-19 has sent Gilead stock on a wild ride.
Signs that air travel is rebounding could lift shares of low-cost carriers focused on the domestic market, notably Southwest Airlines and Spirit Airlines.